Taizhou Volsen Chemical Co., Ltd.
홈페이지> 블로그> Pralsetinib

Pralsetinib

January 15, 2024
Pralsetinib cas number 2097132-94-8 ,also known as GAVRETO, is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. It is used to treat certain cancers caused by abnormal RET genes.iT is a targeted therapy that is taken by mouth once daily. 
문의하기

Author:

Ms. Amy Cheng

이메일:

info@volsenchem.com

Phone/WhatsApp:

008613566652212

인기 상품
Blog News
What is the Tapinarof?

January 02, 2024

Tezacaftor and Ivacaftor

December 29, 2023

You may also like
Related Categories

이 업체에게 이메일로 보내기

제목:
이메일:
메시지:

Your message must be betwwen 20-8000 characters

문의하기

Author:

Ms. Amy Cheng

이메일:

info@volsenchem.com

Phone/WhatsApp:

008613566652212

인기 상품
Blog News
What is the Tapinarof?

January 02, 2024

Tezacaftor and Ivacaftor

December 29, 2023

홈페이지

Product

Phone

우리에 대해

문의

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

송신